Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin-cyclophosphamide +/- BCG: early report of a Southwest Oncology Group study.
D001500:BCG Vaccine / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*
D001500:BCG Vaccine; D004317:Doxorubicin; D003520:Cyclophosphamide